Beta-Blockers for Recent Takotsubo Syndrome
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether starting a beta-blocker (a heart medication that slows the heartbeat and lowers blood pressure) soon after Takotsubo syndrome diagnosis helps prevent complications. You may qualify if you were just diagnosed and have no other serious heart conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with Takotsubo syndrome (broken heart syndrome) in the last 48 hours.
- You must have had a heart catheterization that shows no significant blockages.
- You cannot have severe heart failure or very low blood pressure right now.
- You cannot have a large pressure gradient inside your heart (>30 mmHg) that persists.
- You cannot have had a prior heart attack or severe valve or heart muscle disease.
- You cannot already be taking a beta-blocker medication (like metoprolol or carvedilol).
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether cyclosporine, an immune-related medicine, can improve outcomes in Takotsubo syndrome (a temporary heart muscle problem). It aims to start treatment very soon after a heart catheter test to help the heart recover.
This study looks at Takotsubo (also called stress cardiomyopathy) and heart problems caused by sepsis using specialized heart imaging (including PET). The goal is to better understand what triggers these conditions and how the heart is affected, which may improve diagnosis and care.
This trial studies a psychosocial (emotional and coping) support approach for adults with Takotsubo syndrome. It may help patients deal with stress, anxiety, or adjustment related to the condition.
This study uses MRI to learn more about Takotsubo syndrome (a temporary heart condition often triggered by stress). If you have been diagnosed with Takotsubo and have had certain heart tests, you may be able to join.
This study is a patient registry that collects information from people diagnosed with Takotsubo syndrome, also known as a stress-related heart condition. It may help researchers learn more about who is affected and how the condition behaves over time.
This study enrolls people who have been diagnosed with Takotsubo (a temporary, stress-related heart condition). It aims to better understand Takotsubo by collecting your medical records and analyzing proteins, which may help improve care in the future.
Hear when a new Takotsubo Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.